A pas de deux of osteoporosis and sarcopenia: osteosarcopenia

References

• Johnell O, Kanis JA. An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos Int. 2006;17(12):1726–1733.
   PubMed Web of Science ®Google Scholar
• Barnsley J, Buckland G, Chan PE, et al. Pathophysiology and treatment of osteoporosis: challenges for clinical practice in older people. Aging Clin Exp Res. 2021;33(4):759–715.
   PubMed Web of Science ®Google Scholar
• Rosenberg IH. Sarcopenia: origins and clinical relevance. Clin Geriatr Med. 2011;27(3):337–339.
   PubMed Web of Science ®Google Scholar
• Cruz-Jentoft AJ, Bahat G, Bauer J, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019;48(1):16–31.
   PubMed Web of Science ®Google Scholar
• Oliveira A, Vaz C. The role of sarcopenia in the risk of osteoporotic hip fracture. Clin Rheumatol. 2015;34(10):1673–1680.
   PubMed Web of Science ®Google Scholar
• Janssen I, Shepard DS, Katzmarzyk PT, et al. The healthcare costs of sarcopenia in the United States. J Am Geriatr Soc. 2004;52(1):80–85.
   PubMed Web of Science ®Google Scholar
• Pinedo-Villanueva R, Westbury LD, Syddall HE, et al. Health care costs associated with muscle weakness: a UK population-based estimate. Calcif Tissue Int. 2019;104(2):137–144.
   PubMed Web of Science ®Google Scholar
• Cawthon PM, Manini T, Patel SM, et al. Putative cut-points in sarcopenia components and incident adverse health outcomes: an SDOC analysis. J Am Geriatr Soc. 2020;68(7):1429–1437.
   PubMed Web of Science ®Google Scholar
• Studenski SA, Peters KW, Alley DE, et al. The FNIH sarcopenia project: rationale, study description, conference recommendations, and final estimates. J Gerontol – Ser A Biol Sci Med Sci. 2014;69(5):547–558.
   PubMed Web of Science ®Google Scholar
• Chen LK, Woo J, Assantachai P, et al. Asian Working Group for Sarcopenia: 2019 consensus update on sarcopenia diagnosis and treatment. J Am Med Dir Assoc. 2020;21(3):300.e2–307.e2.
   Web of Science ®Google Scholar
• Huo YR, Suriyaarachchi P, Gomez F, et al. Phenotype of osteosarcopenia in older individuals with a history of falling. J Am Med Dir Assoc. 2015;16(4):290–295.
   PubMed Web of Science ®Google Scholar
• Cevei M, Onofrei RR, Cioara F, et al. Correlations between the quality of life domains and clinical variables in sarcopenic osteoporotic postmenopausal women. JCM. 2020;9(2):441.
   Google Scholar
• Paintin J, Cooper C, Dennison E. Osteosarcopenia. Br J Hosp Med (Lond). 2018;79(5):253–258.
   PubMed Web of Science ®Google Scholar
• Ferretti JL, Capozza RF, Cointry GR, et al. Gender-related differences in the relationship between densitometric values of whole-body bone mineral content and lean body mass in humans between 2 and 87 years of age. Bone. 1998;22(6):683–690.
   PubMed Web of Science ®Google Scholar
• Ilesanmi-Oyelere BL, Coad J, Roy N, et al. Lean body mass in the prediction of bone mineral density in postmenopausal women. Biores Open Access. 2018;7(1):150–158.
   PubMed Web of Science ®Google Scholar
• Leslie WD, Schousboe JT, Morin SN, et al. Loss in DXA-estimated total body lean mass but not fat mass predicts incident major osteoporotic fracture and hip fracture independently from FRAX: a registry-based cohort study. Arch Osteoporos. 2020;15(1):96.
   PubMed Web of Science ®Google Scholar
• Ho-Pham LT, Nguyen UDT, Nguyen TV. Association between lean mass, fat mass, and bone mineral density: a meta-analysis. J Clin Endocrinol Metab. 2014;99(1):30–38.
   PubMed Web of Science ®Google Scholar
• Edwards MH, Gregson CL, Patel HP, et al. Muscle size, strength, and physical performance and their associations with bone structure in the Hertfordshire Cohort Study. J Bone Miner Res. 2013;28(11):2295–2304.
   PubMed Web of Science ®Google Scholar
• Intriago M, Maldonado G, Guerrero R, et al. Bone mass loss and sarcopenia in Ecuadorian Patients. J Aging Res. 2020;2020:1–6.
   Google Scholar
• Locquet M, Beaudart C, Reginster JY, et al. Association between the decline in muscle health and the decline in bone health in older individuals from the SarcoPhAge Cohort. Calcif Tissue Int. 2019;104(3):273–284.
   PubMed Web of Science ®Google Scholar
• Nielsen BR, Andersen HE, Haddock B, et al. Prevalence of muscle dysfunction concomitant with osteoporosis in a home-dwelling Danish population aged 65–93 years – The Copenhagen Sarcopenia Study. Exp Gerontol. 2020;138:110974.
   PubMed Web of Science ®Google Scholar
• Miyakoshi N, Hongo M, Mizutani Y, et al. Prevalence of sarcopenia in Japanese women with osteopenia and osteoporosis. J Bone Miner Metab. 2013;31(5):556–561.
   PubMed Web of Science ®Google Scholar
• Sipilä S, Törmäkangas T, Sillanpää E, et al. Muscle and bone mass in middle‐aged women: role of menopausal status and physical activity. J Cachexia Sarcopenia Muscle. 2020;11(3):698–709.
   PubMed Web of Science ®Google Scholar
• Bauer J, Morley JE, Schols AMWJ, et al. Sarcopenia: a time for action. An SCWD position paper. J Cachexia Sarcopenia Muscle. 2019;10(5):956–961.
   PubMed Web of Science ®Google Scholar
• Buckinx F, Landi F, Cesari M, et al. Pitfalls in the measurement of muscle mass: a need for a reference standard. J Cachexia Sarcopenia Muscle. 2018;9(2):269–278.
   PubMed Web of Science ®Google Scholar
• Stringer HJ, Wilson D. The role of ultrasound as a diagnostic tool for sarcopenia. J Frailty Aging. 2018;7:258–261.
   PubMed Web of Science ®Google Scholar
• Perkisas S, Bastijns S, Baudry S, et al. Application of ultrasound for muscle assessment in sarcopenia: 2020 SARCUS update. Eur Geriatr Med. 2021;12(1):45–59.
   PubMed Web of Science ®Google Scholar
• Compston J, Cooper A, Cooper C, et al. UK clinical guideline for the prevention and treatment of osteoporosis. Arch Osteoporos. 2017;12(1):43.
   PubMed Web of Science ®Google Scholar
• Kanis JA, Hans D, Cooper C, et al. Interpretation and use of FRAX in clinical practice. Osteoporos Int. 2011;22(9):2395–2411.
   PubMed Web of Science ®Google Scholar
• World Health Organization. WHO scientific group on the assessment of osteoporosis at primary health care level Summary Meeting Report; 2004. https://www.who.int/chp/topics/Osteoporosis.pdf
   Google Scholar
• Fahimfar N, Zahedi Tajrishi F, Gharibzadeh S, et al. Prevalence of osteosarcopenia and its association with cardiovascular risk factors in Iranian older people: Bushehr Elderly Health (BEH) program. Calcif Tissue Int. 2020;106(4):364–370.
   PubMed Web of Science ®Google Scholar
• Nielsen BR, Abdulla J, Andersen HE, et al. Sarcopenia and osteoporosis in older people: a systematic review and meta-analysis. Eur Geriatr Med. 2018;9(4):419–434.
   PubMed Web of Science ®Google Scholar
• Wang YJ, Wang Y, Zhan JK, et al. Sarco-osteoporosis: prevalence and association with frailty in Chinese community-dwelling older adults. Int J Endocrinol. 2015;2015:1–8.
   Web of Science ®Google Scholar
• Di Monaco M, Vallero F, Di Monaco R, et al. Prevalence of sarcopenia and its association with osteoporosis in 313 older women following a hip fracture. Arch Gerontol Geriatr. 2011;52(1):71–74.
   PubMed Web of Science ®Google Scholar
• Locquet M, Beaudart C, Bruyère O, et al. Bone health assessment in older people with or without muscle health impairment. Osteoporos Int. 2018;29(5):1057–1067.
   PubMed Web of Science ®Google Scholar
• Lima RM, de Oliveira RJ, Raposo R, et al. Stages of sarcopenia, bone mineral density, and the prevalence of osteoporosis in older women. Arch Osteoporos. 2019;14(1):38.
   PubMed Web of Science ®Google Scholar
• Sjöblom S, Suuronen J, Rikkonen T, et al. Relationship between postmenopausal osteoporosis and the components of clinical sarcopenia. Maturitas. 2013;75(2):175–180.
   PubMed Web of Science ®Google Scholar
• Pereira FB, Leite AF, de Paula AP. Relationship between pre-sarcopenia, sarcopenia and bone mineral density in elderly men. Arch Endocrinol Metab. 2015;59(1):59–65.
   PubMed Web of Science ®Google Scholar
• Sambrook PN, Kelly PJ, Morrison NA, et al. Genetics of osteoporosis. Br J Rheumatol. 1994;33(11):1007–1011.
   PubMedGoogle Scholar
• Tylavsky FA, Bortz AD, Hancock RL, et al. Familial resemblance of radial bone mass between premenopausal mothers and their college-age daughters. Calcif Tissue Int. 1989;45(5):265–272.
   PubMed Web of Science ®Google Scholar
• Trajanoska K, Rivadeneira F, Kiel DP, et al. Genetics of bone and muscle interactions in humans. Curr Osteoporos Rep. 2019;17(2):86–95.
   PubMed Web of Science ®Google Scholar
• Lang DH, Conroy DE, Lionikas A, et al. Bone, muscle, and physical activity: structural equation modeling of relationships and genetic influence with age. J Bone Miner Res. 2009;24(9):1608–1617.
   PubMed Web of Science ®Google Scholar
• Frost HM. Bone's mechanostat: a 2003 update. Anat Rec A Discov Mol Cell Evol Biol. 2003;275(2):1081–1101.
   PubMedGoogle Scholar
• Frost HM. On our age-related bone loss: insights from a new paradigm. J Bone Miner Res. 1997;12(10):1539–1546.
   PubMed Web of Science ®Google Scholar
• Berthelot G, Johnson S, Noirez P, et al. The age-performance relationship in the general population and strategies to delay age related decline in performance. Arch Public Health. 2019;77(1):1–9.
   PubMed Web of Science ®Google Scholar
• Daly RM, Rosengren BE, Alwis G, et al. Gender specific age-related changes in bone density, muscle strength and functional performance in the elderly: a-10 year prospective population-based study. BMC Geriatr. 2013;13(1):71.
   PubMedGoogle Scholar
• Yakabe M, Hosoi T, Akishita M, et al. Updated concept of sarcopenia based on muscle-bone relationship. J Bone Miner Metab. 2020;38(1):7–13.
   PubMed Web of Science ®Google Scholar
• Rudnicki MA, Williams BO. Wnt signaling in bone and muscle. Bone. 2015;80:60–66.
   PubMed Web of Science ®Google Scholar
• Inglis JE, Ilich JZ. The microbiome and osteosarcopenic obesity in older individuals in long-term care facilities. Curr Osteoporos Rep. 2015;13(5):358–362.
   PubMed Web of Science ®Google Scholar
• Baylis D, Bartlett DB, Patel HP, et al. Understanding how we age: insights into inflammaging. Longev Health. 2013;2:1–8.
   PubMedGoogle Scholar
• Franceschi C, Capri M, Garagnani P, et al. Inflammaging. Handb immunosenescence. Switzerland: Springer International Publishing; 2019. p. 1599–1629.
   Google Scholar
• Al Saedi A, Hassan EB, Duque G. The diagnostic role of fat in osteosarcopenia. J Lab Precis Med. 2019;4:7–7.
   Google Scholar
• Sullivan SD, Sarrel PM, Nelson LM. Hormone replacement therapy in young women with primary ovarian insufficiency and early menopause. Fertil Steril. 2016;106(7):1588–1599.
   PubMed Web of Science ®Google Scholar
• Tiidus PM. Benefits of estrogen replacement for skeletal muscle mass and function in post-menopausal females: evidence from human and animal studies. Eurasian J Med. 2011;43(2):109–114.
   PubMedGoogle Scholar
• Zanker J, Duque G. Osteoporosis in older persons: old and new players. J Am Geriatr Soc. 2019;67(4):831–840.
   PubMed Web of Science ®Google Scholar
• Law MR, Hackshaw AK. A meta-analysis of cigarette smoking, bone mineral density and risk of hip fracture: recognition of a major effect. BMJ. 1997;315(7112):841–846.
   PubMed Web of Science ®Google Scholar
• Szulc P, Duboeuf F, Marchand F, et al. Hormonal and lifestyle determinants of appendicular skeletal muscle mass in men: the MINOS study 1-3. Am J Clin Nutr. 2004;80(2):496–503.
   PubMed Web of Science ®Google Scholar
• Steffl M, Bohannon RW, Sontakova L, et al. Relationship between sarcopenia and physical activity in older people: a systematic review and meta-analysis. Clin Interv Aging. 2017;12:835–845.
   PubMed Web of Science ®Google Scholar
• Renoud A, Ecochard R, Marchand F, et al. Predictive parameters of accelerated muscle loss in men – MINOS study. Am J Med. 2014;127(6):554–561.
   PubMed Web of Science ®Google Scholar
• Lee SG, Lee YH, Kim KJ, et al. Additive association of vitamin D insufficiency and sarcopenia with low femoral bone mineral density in noninstitutionalized elderly population: the Korea National Health and Nutrition Examination Surveys 2009–2010. Osteoporos Int. 2013;24(11):2789–2799.
   PubMed Web of Science ®Google Scholar
• Reid IR, Bolland MJ. Skeletal and nonskeletal effects of vitamin D: is vitamin D a tonic for bone and other tissues? Osteoporos Int. 2014;25(10):2347–2357.
   PubMed Web of Science ®Google Scholar
• Gunton JE, Girgis CM. Vitamin D and muscle. Bone Rep. 2018;8:163–167.
   PubMedGoogle Scholar
• Gordeladze JO, Haugen HJ, Johnsen GF, et al. Vitamin K2 facilitating inter-organ cross-talk. In: Gordeladze JO, editor. Vitamin K2 - vital for health and wellbeing. London: IntechOpen; 2017. p. 199–214.
   Google Scholar
• Rønning SB, Pedersen ME, Berg RS, et al. Vitamin K2 improves proliferation and migration of bovine skeletal muscle cells in vitro. PLoS One. 2018;13(4):e0195432.
   PubMed Web of Science ®Google Scholar
• Beaudart C, Dawson A, Shaw SC, et al. Nutrition and physical activity in the prevention and treatment of sarcopenia: systematic review. Osteoporos Int. 2017;28(6):1817–1833.
   PubMed Web of Science ®Google Scholar
• Rong K, Liu XY, Wu XH, et al. Increasing level of leisure physical activity could reduce the risk of hip fracture in older women: a dose-response meta-analysis of prospective cohort studies. Medicine (Baltimore). 2016;95(11):e2984.
   PubMed Web of Science ®Google Scholar
• Daly RM, Gianoudis J, Kersh ME, et al. Effects of a 12-month supervised, community-based, multimodal exercise program followed by a 6-month research-to-practice transition on bone mineral density, trabecular microarchitecture, and physical function in older adults: a randomized controlled trial. J Bone Miner Res. 2020;35(3):419–429.
   PubMed Web of Science ®Google Scholar
• Kirk B, Mooney K, Cousins R, et al. Effects of exercise and whey protein on muscle mass, fat mass, myoelectrical muscle fatigue and health-related quality of life in older adults: a secondary analysis of the Liverpool Hope University–Sarcopenia Ageing Trial (LHU-SAT). Eur J Appl Physiol. 2020;120(2):493–503.
   PubMed Web of Science ®Google Scholar
• Hamaguchi K, Kurihara T, Fujimoto M, et al. The effects of low-repetition and light-load power training on bone mineral density in postmenopausal women with sarcopenia: a pilot study. BMC Geriatr. 2017;17(1):102.
   PubMedGoogle Scholar
• Giangregorio LM, McGill S, Wark JD, et al. Too fit to fracture: outcomes of a Delphi consensus process on physical activity and exercise recommendations for adults with osteoporosis with or without vertebral fractures. Osteoporos Int. 2015;26(3):891–910.
   PubMed Web of Science ®Google Scholar
• Atlihan R, Kirk B, Duque G. Non-pharmacological interventions in osteosarcopenia: a systematic review. J Nutr Health Aging. 2021;25(1):25–32.
   PubMed Web of Science ®Google Scholar
• Daly RM. Exercise and nutritional approaches to prevent frail bones, falls and fractures: an update. Climacteric. 2017;20(2):119–124.
   PubMed Web of Science ®Google Scholar
• Campbell WW, Trappe TA, Wolfe RR, et al. The recommended dietary allowance for protein may not be adequate for older people to maintain skeletal muscle. J Gerontol A Biol Sci Med Sci. 2001;56(6):M373–380.
   PubMed Web of Science ®Google Scholar
• Mendonça N, Hengeveld LM, Visser M, et al. Low protein intake, physical activity, and physical function in European and North American community-dwelling older adults: a pooled analysis of four longitudinal aging cohorts. Am J Clin Nutr. 2021;114(1):29–41.
   PubMed Web of Science ®Google Scholar
• Bauer J, Biolo G, Cederholm T, et al. Evidence-based recommendations for optimal dietary protein intake in older people: a position paper from the PROT-AGE Study Group. J Am Med Dir Assoc. 2013;14(8):542–549.
   PubMed Web of Science ®Google Scholar
• Morton RW, Murphy KT, Mckellar SR, et al. A systematic review, meta-analysis and meta-regression of the effect of protein supplementation on resistance training-induced gains in muscle mass and strength in healthy adults. Br J Sports Med. 2018;52(6):376–384.
   PubMed Web of Science ®Google Scholar
• Liao C-D, Chen H-C, Huang S-W, et al. The role of muscle mass gain following protein supplementation plus exercise therapy in older adults with sarcopenia and frailty risks: a systematic review and meta-regression analysis of randomized trials. Nutrients. 2019;11(8):1713.
   Web of Science ®Google Scholar
• De Rui M, Inelmen EM, Pigozzo S, et al. Dietary strategies for mitigating osteosarcopenia in older adults: a narrative review. Aging Clin Exp Res. 2019;31(7):897–903.
   PubMed Web of Science ®Google Scholar
• Bonjour J-P, Kraenzlin M, Levasseur R, et al. Dairy in adulthood: from foods to nutrient interactions on bone and skeletal muscle health. J Am Coll Nutr. 2013;32(4):251–263.
   PubMed Web of Science ®Google Scholar
• Luo D, Lin Z, Li S, et al. Effect of nutritional supplement combined with exercise intervention on sarcopenia in the elderly: a meta-analysis. Int J Nurs Sci. 2017;4(4):389–401.
   PubMed Web of Science ®Google Scholar
• Finger D, Goltz FR, Umpierre D, et al. Effects of protein supplementation in older adults undergoing resistance training: a systematic review and meta-analysis. Sports Med. 2015;45(2):245–255.
   PubMed Web of Science ®Google Scholar
• Hill TR, Aspray TJ. The role of vitamin D in maintaining bone health in older people. Ther Adv Musculoskelet Dis. 2017;9(4):89–95.
   PubMed Web of Science ®Google Scholar
• Bischoff-Ferrari HA, Dawson-Hughes B, Stöcklin E, et al. Oral supplementation with 25(OH)D3 versus vitamin D3: Effects on 25(OH)D levels, lower extremity function, blood pressure, and markers of innate immunity. J Bone Miner Res. 2012;27(1):160–169.
   PubMed Web of Science ®Google Scholar
• Antimo GI, Alessandro M, Dario S, et al. Effectiveness of calcifediol in improving muscle function in post-menopausal women: a prospective cohort study. Adv Ther. 2017;34:744–752.
   PubMed Web of Science ®Google Scholar
• Rizzoli R, Stevenson JC, Bauer JM, et al. The role of dietary protein and vitamin D in maintaining musculoskeletal health in postmenopausal women: a consensus statement from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO). Maturitas. 2014;79(1):122–132.
   PubMed Web of Science ®Google Scholar
• Sanders KM, Stuart AL, Williamson EJ, et al. Annual high-dose oral vitamin D and falls and fractures in older women: a randomized controlled trial. JAMA. 2010;303(18):1815–1822.
   PubMed Web of Science ®Google Scholar
• Bruyère O, Cavalier E, Reginster JY. Vitamin D and osteosarcopenia: an update from epidemiological studies. Curr Opin Clin Nutr Metab Care. 2017;20(6):498–503.
   PubMed Web of Science ®Google Scholar
• Fatima M, Brennan-Olsen SL, Duque G. Therapeutic approaches to osteosarcopenia: insights for the clinician. Ther Adv Musculoskelet Dis. 2019;11:1759720X19867009.
   PubMed Web of Science ®Google Scholar
• Girgis CM, Mokbel N, DiGirolamo DJ. Therapies for musculoskeletal disease: can we treat two birds with one stone? Curr Osteoporos Rep. 2014;12(2):142–153.
   PubMed Web of Science ®Google Scholar
• Dalle S, Rossmeislova L, Koppo K. The role of inflammation in age-related sarcopenia. Front Physiol. 2017;8:1045.
   PubMed Web of Science ®Google Scholar
• Greig CA, Atherton PJ, Rennie MJ. Can an NSAID a day keep muscle wasting away? J Physiol. 2009;587(Pt 24):5799–5800.
   PubMed Web of Science ®Google Scholar
• Landi F, Marzetti E, Liperoti R, et al. Nonsteroidal anti-inflammatory drug (NSAID) use and sarcopenia in older people: results from the ilsirente study. J Am Med Dir Assoc. 2013;14(8):626.e9-626–e13.
   Web of Science ®Google Scholar
• Bondesen BA, Mills ST, Kegley KM, et al. The COX-2 pathway is essential during early stages of skeletal muscle regeneration. Am J Physiol Cell Physiol. 2004;287:475–483.
   PubMed Web of Science ®Google Scholar
• Snyder PJ, Bhasin S, Cunningham GR, et al. Lessons from the testosterone trials. Endocr Rev. 2018;39(3):369–386.
   PubMed Web of Science ®Google Scholar
• Wittert GA, Chapman IM, Haren MT, et al. Oral testosterone supplementation increases muscle and decreases fat mass in healthy elderly males with low-normal gonadal status. J Gerontol A Biol Sci Med Sci. 2003;58(7):618–625.
   PubMed Web of Science ®Google Scholar
• Greeves JP, Cable NT, Reilly T, et al. Changes in muscle strength in women following the menopause: a longitudinal assessment of the efficacy of hormone replacement therapy. Clin Sci (Lond). 1999;97(1):79–84.
   PubMed Web of Science ®Google Scholar
• Kim SW, Kim R. The association between hormone therapy and sarcopenia in postmenopausal women: the Korea National Health and Nutrition Examination Survey, 2008–2011. Menopause. 2020;27(5):506–511.
   PubMed Web of Science ®Google Scholar
• Mohler ML, Bohl CE, Jones A, et al. Nonsteroidal selective androgen receptor modulators (SARMs): dissociating the anabolic and androgenic activities of the androgen receptor for therapeutic benefit. J Med Chem. 2009;52(12):3597–3617.
   PubMed Web of Science ®Google Scholar
• Dalton JT, Barnette KG, Bohl CE, et al. The selective androgen receptor modulator GTx-024 (enobosarm) improves lean body mass and physical function in healthy elderly men and postmenopausal women: results of a double-blind, placebo-controlled phase II trial. J Cachexia Sarcopenia Muscle. 2011;2(3):153–161.
   PubMed Web of Science ®Google Scholar
• Barake M, Arabi A, Nakhoul N, et al. Effects of growth hormone therapy on bone density and fracture risk in age-related osteoporosis in the absence of growth hormone deficiency: a systematic review and meta-analysis. Endocrine. 2018;59(1):39–49.
   PubMed Web of Science ®Google Scholar
• Cummings SR, Martin JS, McClung MR, et al. Denosumab for prevention of fractures in postmenopausal women with osteoporosis. N Engl J Med. 2009;361(8):756–765.
   PubMed Web of Science ®Google Scholar
• Bonnet N, Bourgoin L, Biver E, et al. RANKL inhibition improves muscle strength and insulin sensitivity and restores bone mass. J Clin Invest. 2019;129(8):3214–3223.
   PubMed Web of Science ®Google Scholar
• Phu S, Bani Hassan E, Vogrin S, et al. Effect of denosumab on falls, muscle strength, and function in community-dwelling older adults. J Am Geriatr Soc. 2019;67(12):2660–2661.
   PubMed Web of Science ®Google Scholar
• McPherron AC, Lawler AM, Lee SJ. Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member. Nature. 1997;387(6628):83–90.
   PubMed Web of Science ®Google Scholar
• Patel HP, Al-Shanti N, Davies LC, et al. Lean mass, muscle strength and gene expression in community dwelling older men: findings from the Hertfordshire Sarcopenia Study (HSS). Calcif Tissue Int. 2014;95(4):308–316.
   PubMed Web of Science ®Google Scholar
• Han D-S, Chen Y-M, Lin S-Y, et al. Serum myostatin levels and grip strength in normal subjects and patients on maintenance haemodialysis. Clin Endocrinol (Oxf). 2011;75(6):857–863.
   PubMed Web of Science ®Google Scholar
• Whittemore LA, Song K, Li X, et al. Inhibition of myostatin in adult mice increases skeletal muscle mass and strength. Biochem Biophys Res Commun. 2003;300(4):965–971.
   PubMed Web of Science ®Google Scholar
• Becker C, Lord SR, Studenski SA, et al. Myostatin antibody (LY2495655) in older weak fallers: a proof-of-concept, randomised, phase 2 trial. Lancet Diabetes Endocrinol. 2015;3(12):948–957.
   PubMed Web of Science ®Google Scholar
• Rooks D, Praestgaard J, Hariry S, et al. Treatment of sarcopenia with bimagrumab: results from a phase ii, randomized, controlled, proof-of-concept study. J Am Geriatr Soc. 2017;65(9):1988–1995.
   PubMed Web of Science ®Google Scholar
• Rooks D, Swan T, Goswami B, et al. Bimagrumab vs Optimized standard of care for treatment of sarcopenia in community-dwelling older adults: a randomized clinical trial. JAMA Netw Open. 2020;3(10):e2020836.
   PubMed Web of Science ®Google Scholar
• Colaianni G, Mongelli T, Cuscito C, et al. Irisin prevents and restores bone loss and muscle atrophy in hind-limb suspended mice. Sci Rep. 2017;7(1):16.
   PubMedGoogle Scholar
• Park HS, Kim HC, Zhang D, et al. The novel myokine irisin: clinical implications and potential role as a biomarker for sarcopenia in postmenopausal women. Endocrine. 2019;64(2):341–348.
   PubMed Web of Science ®Google Scholar
• Bermeo S, Al Saedi A, Vidal C, et al. Treatment with an inhibitor of fatty acid synthase attenuates bone loss in ovariectomized mice. Bone. 2019;122:114–122.
   PubMed Web of Science ®Google Scholar
• Coto-Montes A, Boga J, Tan D, et al. Melatonin as a potential agent in the treatment of sarcopenia. IJMS. 2016;17(10):1771.
   Google Scholar
• Pal China S, Pal S, Chattopadhyay S, et al. Globular adiponectin reverses osteo-sarcopenia and altered body composition in ovariectomized rats. Bone. 2017;105:75–86.
   PubMed Web of Science ®Google Scholar
• Rong S, Wang L, Peng Z, et al. The mechanisms and treatments for sarcopenia: could exosomes be a perspective research strategy in the future? J Cachexia Sarcopenia Muscle. 2020;11(2):348–365.
   PubMed Web of Science ®Google Scholar